Sequenta's Series C Round

Sequenta raised a round of funding on July 02, 2013.

Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…

Articles about Sequenta's Series C Round: